PharmaSGP Holding SE (FRA:PSG)
Germany
· Delayed Price · Currency is EUR 27.80
0.00 (0.00%)
Last updated: May 13, 2025
PharmaSGP Holding SE Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Revenue | 118.84 | 101.1 | 85.82 | 65.34 | 63.25 | Upgrade
|
| Revenue Growth (YoY) | 17.54% | 17.80% | 31.34% | 3.32% | 1.07% | Upgrade
|
| Cost of Revenue | 10.85 | 9.46 | 9.03 | 6.49 | 6.21 | Upgrade
|
| Gross Profit | 107.99 | 91.64 | 76.79 | 58.86 | 57.04 | Upgrade
|
| Selling, General & Admin | 61.3 | 50.72 | 44.29 | 35.53 | 35.42 | Upgrade
|
| Other Operating Expenses | 9.65 | 6.91 | 5.57 | 4.83 | 5.64 | Upgrade
|
| Operating Expenses | 80.35 | 67 | 59.05 | 43.83 | 41.54 | Upgrade
|
| Operating Income | 27.64 | 24.64 | 17.75 | 15.02 | 15.5 | Upgrade
|
| Interest Expense | -4.14 | -4.41 | -2.01 | -0.64 | -0.1 | Upgrade
|
| Interest & Investment Income | 0.04 | 0.24 | 0.05 | - | 0.01 | Upgrade
|
| Currency Exchange Gain (Loss) | 1.36 | 0.91 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 1.14 | 0.52 | 0.08 | -0.07 | -0 | Upgrade
|
| EBT Excluding Unusual Items | 26.04 | 21.89 | 15.87 | 14.31 | 15.4 | Upgrade
|
| Asset Writedown | - | - | -0.06 | -0.11 | - | Upgrade
|
| Other Unusual Items | - | - | - | - | -1.25 | Upgrade
|
| Pretax Income | 26.04 | 21.89 | 15.8 | 14.21 | 14.15 | Upgrade
|
| Income Tax Expense | 6.51 | 5.5 | 3.85 | 3.52 | 3.51 | Upgrade
|
| Net Income | 19.54 | 16.4 | 11.95 | 10.69 | 10.64 | Upgrade
|
| Net Income to Common | 19.54 | 16.4 | 11.95 | 10.69 | 10.64 | Upgrade
|
| Net Income Growth | 19.14% | 37.17% | 11.82% | 0.47% | -36.31% | Upgrade
|
| Shares Outstanding (Basic) | 12 | 12 | 12 | 12 | 12 | Upgrade
|
| Shares Outstanding (Diluted) | 12 | 12 | 12 | 12 | 12 | Upgrade
|
| Shares Change (YoY) | -0.99% | -0.06% | - | - | - | Upgrade
|
| EPS (Basic) | 1.65 | 1.37 | 1.00 | 0.89 | 0.89 | Upgrade
|
| EPS (Diluted) | 1.65 | 1.37 | 1.00 | 0.89 | 0.89 | Upgrade
|
| EPS Growth | 20.33% | 37.25% | 11.82% | 0.47% | -36.31% | Upgrade
|
| Free Cash Flow | 24.8 | 26.59 | 24.59 | 12.15 | 15.04 | Upgrade
|
| Free Cash Flow Per Share | 2.09 | 2.22 | 2.05 | 1.01 | 1.25 | Upgrade
|
| Dividend Per Share | 0.510 | 1.360 | 0.490 | 0.450 | - | Upgrade
|
| Dividend Growth | -62.50% | 177.55% | 8.89% | - | - | Upgrade
|
| Gross Margin | 90.87% | 90.64% | 89.48% | 90.07% | 90.19% | Upgrade
|
| Operating Margin | 23.26% | 24.37% | 20.68% | 22.99% | 24.51% | Upgrade
|
| Profit Margin | 16.44% | 16.22% | 13.93% | 16.36% | 16.82% | Upgrade
|
| Free Cash Flow Margin | 20.87% | 26.30% | 28.66% | 18.59% | 23.78% | Upgrade
|
| EBITDA | 36.34 | 33.3 | 26.37 | 18.08 | 15.67 | Upgrade
|
| EBITDA Margin | 30.58% | 32.94% | 30.73% | 27.67% | 24.77% | Upgrade
|
| D&A For EBITDA | 8.7 | 8.67 | 8.62 | 3.06 | 0.17 | Upgrade
|
| EBIT | 27.64 | 24.64 | 17.75 | 15.02 | 15.5 | Upgrade
|
| EBIT Margin | 23.26% | 24.37% | 20.68% | 22.99% | 24.51% | Upgrade
|
| Effective Tax Rate | 24.98% | 25.10% | 24.36% | 24.75% | 24.80% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.